The Meningioma Brain Tumor Network, Inc. (MBTN) is proud to announce that Dr. Joh Evans Coleman, Founder and CEO of MBTN, will serve as a featured speaker at the upcoming Neuro‑Oncology Symposium hosted by the University of Arizona College of Medicine – Phoenix, HonorHealth, and Banner Health on October 17, 2026. This year’s symposium brings together leading clinicians, researchers, and patient‑advocacy organizations to explore the latest innovations in brain and spine tumor

Spotlight Speaker Presentation: Dr. Ekokobe Fonkem, DO — Neurologist–Neuro-Oncologist This summary captures the substance and spirit of Dr. Ekokobe Fonkem’s Spotlight Speaker presentation, delivered during MBTN’s 90-minute global webinar. It is written for the full community that the webinar was designed to serve — physicians and clinicians, meningioma survivor-thrivers and their families, caregivers, healthcare partners, community advocates, and grant funders alike — so that

Join the Meningioma Brain Tumor Network (MBTN) on Saturday, June 20th, for a powerful 90-minute global webinar: The Meningioma Enigma: Science, Lived Experience & Quality of Life! 🧠🌐 We are bringing together top medical experts and incredible survivor-thrivers for an interactive event dedicated to bridging the gap between clinical research and daily reality. During the event, we’ll be exploring: ✨ Navigating health-related quality of life outcomes. ✨ Addressing ps

The Meningioma Brain Tumor Network (MBTN) is proud to announce its upcoming global webinar, The Meningioma Enigma: Science, Lived Experience & Health‑Related Quality of Life, scheduled for June 20, 2026. This landmark event brings together leading experts in neuro‑oncology, clinical research, and survivor‑thriver advocacy to illuminate the complex realities of meningioma — the most prevalent primary brain tumor worldwide. Despite its frequency, meningioma remains widely misun

MBTN’s Survivor-Thriver Speaks program is a crucial platform that brings attention to often-neglected psychosocial symptoms experienced by patients throughout diagnosis and treatment. These symptoms—ranging from emotional distress and social isolation to anxiety and depression—can profoundly affect an individual’s overall health-related quality of life (HRQoL). By acknowledging and addressing these critical issues during diagnosis, our program aims to mitigate the long-term c